Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Reviews Endocrinol 14(2):115–125

Article  CAS  Google Scholar 

Soto-Pedre E, Newey PJ, Leese GP (2023) Stable incidence and increasing prevalence of primary hyperparathyroidism in a population-based study in Scotland. J Clin Endocrinol Metabolism :dgad201

Silva BC, Cusano NE, Bilezikian JP (2018) Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32(5):593–607

Article  CAS  PubMed  Google Scholar 

Clagett GP, Anderson FA, Heit J, Levine MN, Wheeler HB (1995) Prevention of venous thromboembolism. Chest 108(4):312S–334S

Article  CAS  PubMed  Google Scholar 

Brotman DJ, Deitcher SR, Lip GY, Matzdorff AC (2004) Virchow’s triad revisited. South Med J 97(2):213–215

Article  PubMed  Google Scholar 

Green D (2006) Coagulation cascade. Hemodial Int 10(S2):S2–S4

Article  PubMed  Google Scholar 

Rockville M (2012)

Koufakis T, Antonopoulou V, Grammatiki M, Karras SN, Ajjan R, Zebekakis P et al (2018) The relationship between primary hyperparathyroidism and thrombotic events: report of three cases and a review of potential mechanisms. Int J Hematology-Oncology Stem Cell Res 12(3):175

Google Scholar 

Pringle A, Smith E (1964) Renal vein thrombosis in acute hyperparathyroidism. Br Med J 2(5410):675

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franchello A, Camandona M, Gasparri G (2010) Acute hyperparathyroidism and vascular thrombosis; an unrecognized association. J Endocrinol Invest 33(9):683

Article  CAS  PubMed  Google Scholar 

Chen L, Zhang Z (2017) Catastrophic femoral vein thrombosis in a patient with hypercalcemia due to parathyroid adenoma: a case report. J Emerg Crit Care Med 1:2

Article  Google Scholar 

Orlova M, Zin YJ, Posadas Martínez ML, Grande Ratti MF, Giunta DH, Burgos M, Vázquez FJ Incidence of venous thromboembolic disease during primary hyperparathyroidism: a 20-year single Center study [abstract]. Res Pract Thromb Haemost 2021:5 (Suppl 2).

Mundy GR, Guise TA (1997) Hypercalcemia of malignancy. Am J Med 103(2):134–145

Article  CAS  PubMed  Google Scholar 

Xiong W, Zhao Y, Xiong Y, Xu M, Pudasaini B, Du H et al (2020) Coagulation factor IV is an indicator of symptomatic pulmonary embolism in patients with primary lung cancer. Clin Respir J 14(2):124–131

Article  CAS  PubMed  Google Scholar 

Coagulation disorders in uremia (2006) Seminars in nephrology: Elsevier;

Huang M, Wei R, Wang Y, Su T, Di P, Li Q et al (2017) Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ open 7(5):e014294

Article  PubMed  PubMed Central  Google Scholar 

Boström H, Alveryd A (1972) Stroke in hyperparathyroidism. Acta Med Scand 192(1–6):299–308

Article  PubMed  Google Scholar 

Gorelick PB, Sloan MA (2008) Calcium, hypercalcemia, magnesium, and brain ischemia. Uncommon causes of stroke, 2nd Edition. Cambridge University Press, pp 357–364

Kannan M, Ahmad F, Saxena R (2019) Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings. Blood Rev 37:100583

Article  CAS  PubMed  Google Scholar 

Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederle B, Weidinger F et al (1998) Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 40(2):396–401

Article  CAS  PubMed  Google Scholar 

Held JM, Daily J, Kilfoil T, Johnston M (2018) Resolution of Raynaud’s symptoms after parathyroidectomy. Am Surg 84(8):E323–E324

Article  PubMed  Google Scholar 

Koubaity O, Mandry D, Nguyen-Thi P, Bihain F, Nomine-Criqui C, Demarquet L et al (2020) Coronary artery disease is more severe in patients with primary hyperparathyroidism. Surgery 167(1):149–154

Article  PubMed  Google Scholar 

Streeten EA, Munir K, Hines S, Mohamed A, Mangano C, Ryan KA et al (2008) Coronary artery calcification in patients with primary hyperparathyroidism in comparison with control subjects from the multi-ethnic study of atherosclerosis. Endocr Pract 14(2):155–161

Article  PubMed  Google Scholar 

Alay M, Ercek BM, Sonmez GM, Sakin A, Ucler R, Yildiz S (2020) Evaluation of coagulation parameters in patients with parathyroid adenoma. Sci Rep 10(1):19208

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castoldi E, Hackeng TM (2008) Regulation of coagulation by protein S. Curr Opin Hematol 15(5):529–536

Article  CAS  PubMed  Google Scholar 

Hoppe B (2014) Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation. Thromb Haemost 112(10):649–658

Article  PubMed  Google Scholar 

Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O (2009) Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism. Eur J Endocrinol 160(5):863–868

Article  CAS  PubMed  Google Scholar 

Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO (2008) :619–624

Swieringa F, Spronk HM, Heemskerk JW, van der Meijden, Paola EJ (2018) Integrating platelet and coagulation activation in fibrin clot formation. Res Pract Thromb Haemostasis 2(3):e12107

Google Scholar 

Yorulmaz G, Kalkan AT, Akalin A, Alagüney ES, Gündüz E, Badak B et al (2021) Effect of hyperparathyroidism on coagulation: a global assessment by modifiedrotation thromboelastogram (ROTEM). Turk J Med Sci 51(6):2897–2902

Article  CAS  PubMed  Google Scholar 

Elbers LP, Wijnberge M, Meijers JC, Poland DC, Brandjes DP, Fliers E et al (2018) Coagulation and fibrinolysis in hyperparathyroidism secondary to vitamin D deficiency. Endocr Connections 7(2):325–333

Article  CAS  Google Scholar 

Yorulmaz G, Akalın A, Akay OM, Şahin G, Bal C (2016) The effect of hyperparathyroid state on platelet functions and bone loss. Turkish J Hematol 33(4):293

Article  CAS  Google Scholar 

Shekarkhar S, Foroughi M, Moatamedi M, Gachkar L (2014) The association of serum parathyroid hormone and severity of coronary artery diseases. Coron Artery Dis 25(4):339–342

Article  PubMed  Google Scholar 

Fujii H (2018) Association between parathyroid hormone and cardiovascular disease. Therapeutic Apheresis and Dialysis 22(3):236–241

Article  PubMed  Google Scholar 

Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J et al (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21):2765–2771

Article  PubMed  Google Scholar 

Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A (2012) Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 44:541–547

Article  CAS  PubMed  Google Scholar 

Frey S, Mirallié É, Cariou B, Blanchard C (2021) Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: a narrative review. Nutr Metabolism Cardiovasc Dis 31(4):981–996

Article  CAS  Google Scholar 

Cunningham J, Danese M, Olson K, Klassen P, Chertow GM (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68(4):1793–1800

Article  CAS  PubMed  Google Scholar 

Mitnick MA, Grey A, Masiukiewicz U, Bartkiewicz M, Rios-Velez L, Friedman S et al (2001) Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiology-Endocrinology Metabolism 280(3):E405–E412

Article  CAS  Google Scholar 

Pirih FQ, Michalski MN, Cho SW, Koh AJ, Berry JE, Ghaname E et al (2010) Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6. PLoS ONE 5(10):e13657

Article  PubMed  PubMed Central  Google Scholar 

Kerr R, Stirling D, Ludlam CA (2001) Interleukin 6 and haemostasis. Br J Haematol 115(1):3–12

Article  CAS  PubMed  Google Scholar 

Zhang Y, Zhang Z, Wei R, Miao X, Sun S, Liang G et al (2020) IL (interleukin)-6 contributes to deep vein thrombosis and is negatively regulated by miR-338-5p. Arterioscler Thromb Vasc Biol 40(2):323–334

Article  CAS  PubMed  Google Scholar 

Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP et al (1996) Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 76(11):738–742

CAS  PubMed  Google Scholar 

Farmakis IT, Barco S, Mavromanoli AC, Agnelli G, Cohen AT, Giannakoulas G et al (2022) Cost-of‐illness analysis of Long‐Term Health Care Resource Use and Disease Burden in patients with Pulmonary Embolism: insights from the PREFER in VTE Registry. J Am Heart Association 11(20):e027514

Article  Google Scholar